Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
198 Leser
Artikel bewerten:
(1)

Intelligent Technology Empowers the Future of Rehabilitation: Siyi Intelligence (Syrebo) Shines at WRRC 2024

i-CREATe & WRRC 2024

SHANGHAI, Sept. 9, 2024 /PRNewswire/ -- Siyi Intelligence (Syrebo) played a prominent role at the International Convention on Rehabilitation Engineering and Assistive Technology (i-CREATe 2024) & the World Rehabilitation Robot Convention 2024 (WRRC 2024), held in Shanghai from August 23rd to 26th, 2024.

This event was co-hosted by the Coalition on Rehabilitation Engineering and Assistive Technology of Asia (CREATe Asia), the China Association of Assistive products, and the University of Shanghai for Science and Technology. The Institute of Electrical and Electronics Engineers (IEEE), the world's largest academic organization, acted as technical sponsor. Prof. Hongliu Yu, President-elect of CREATe Asia, served as the convention chairman, joining an already impressive roster of participants.

Siyi Intelligence (Syrebo) showcased the company's intelligent rehabilitation solutions, capturing the attention of rehabilitation professionals worldwide.

Crowded Booth and Rave Reviews

Siyi Intelligence (Syrebo), a leader in the rehabilitation industry, made a remarkable debut at the event with its array of intelligent rehabilitation products. The line-up included the Syrebo® series of solutions, including the Brain-Computer Interface Rehabilitation Training & Evaluation System, the Intelligent Upper Limb Rehabilitation Robot, and the Hand Rehabilitation Robot.

The unveiling of the solutions line-up attracted a large number of attendees eager to experience the innovations firsthand. The products received rave reviews from visitors for their cutting-edge technology and user-friendly design. Additionally, Prof. Jie Jia from Fudan University's Huashan Hospital, a prominent guest at the event, visited the Siyi Intelligence (Syrebo) booth and provided valuable feedback on the design and clinical utility of their smart rehabilitation solutions.


Honored Participation in the Global Entrepreneurship Competition

On August 23rd, Siyi Intelligence (Syrebo) participated in the final round of the Global Rehabilitation Robot Entrepreneurship Competition with its award-winning Syrebo® Brain-Computer Interface Rehabilitation Training and Evaluation System. Prior honors include the Red Dot and iF Design Awards.

After intense competition and detailed evaluation by the final judges, Siyi Intelligence's (Syrebo) brain-computer interface distinguished itself with its unique design and advanced technology, ultimately winning the Best Prototype Award.

Insightful Speech at the Hand Rehabilitation Forum

The Forum on New Technologies and Devices for Hand Rehabilitation was held on August 25th at the conference venue. The forum was co-presided by Prof. Jie Jia and Prof. Qiyu Tang from the Chinese University of Hong Kong.

During the forum, Wudong Wang, co-founder of Siyi Intelligence (Syrebo), delivered a presentation on the innovative application of intelligent rehabilitation technology in hand rehabilitation. His insights offered fresh perspectives and cutting-edge ideas, contributing significantly to the advancement of the field.


About Siyi Intelligence (Syrebo)

Siyi Intelligence(Syrebo) is a pioneering neurorehabilitation company that offers a range of affordable robotic products designed for hospitals, clinics and individual use. The product line-up includes soft hand function robotics, soft exoskeletons for lower limbs, Brain-Computer Interface (BCl) solutions and upper limb rehabilitation robotics.

Syrebo® soft hand robotic series is equipped to provide advanced training solutions utilizing BCl, Electromyography (EMG), flexible sensors and Electrical Nerve Stimulation (ENS). Syrebo® upper limb rehabilitation robotics feature high precision optical positioning, suitable for varied environments. For mobility challenges, Syrebo® soft robotics for walking provide detailed gait analysis and assistance to patients with neurological injuries, including stroke and multiple sclerosis victims.

Certified by the FDA and CE, Syrebo® products have been available globally across more than 80 countries and regions since 2017, serving over 4,000 hospitals and 60,000 families.

The mission is to lead the market in developing affordable, high-quality rehabilitation robotics and services, catering to the needs of hospitals, clinics, and families globally.

Photo - https://mma.prnewswire.com/media/2498412/20240906155535.jpg
Photo - https://mma.prnewswire.com/media/2498411/20240906155545.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/intelligent-technology-empowers-the-future-of-rehabilitation-siyi-intelligence-syrebo-shines-at-wrrc-2024-302241854.html

© 2024 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.